Table 3. Analyses of 1st-borns with and without other siblings (as of March 31st 2011).
Birth order | Events During Risk Period (Days 0–2) | Events During Control Period (Days 9–18) | Relative Incidence (95% CI) | Relative Incidence Ratio (95% CI) | RIR p-value |
2-month Vaccination | |||||
2nd or higher | 418 | 1840 | 0.68 (0.61–0.76) | 1 (Ref) | |
1st with siblings | 248 | 748 | 0.99 (0.86–1.15) | 1.46 (1.22–1.74) | <0.0001* |
1st with no siblings# | 326 | 1101 | 0.89 (0.79–1.01) | 1.30 (1.11–1.53) | <0.0015∧ |
4-month vaccination | |||||
2nd or higher | 310 | 1713 | 0.54 (0.48–0.61) | 1 (Ref) | |
1st with siblings | 198 | 652 | 0.91 (0.78–1.07) | 1.68 (1.37–2.05) | <0.0001* |
1st with no siblings# | 286 | 919 | 0.93 (0.82–1.07) | 1.72 (1.44–2.06) | <0.0001∧ |
6-month vaccination | |||||
2nd or higher | 358 | 1808 | 0.59 (0.53–0.67) | 1 (Ref) | |
1st with siblings | 213 | 792 | 0.80 (0.68–0.93) | 1.34 (1.11–1.62) | <0.0026* |
1st with no siblings# | 271 | 1082 | 0.72 (0.63–0.83) | 1.22 (1.02–1.45) | <0.0283∧ |
12-month vaccination | |||||
2nd or higher | 2338 | 1845 | 1.27 (1.19–1.35) | 1 (Ref) | |
1st with siblings | 1450 | 960 | 1.51 (1.39–1.64) | 1.19 (1.08–1.32) | <0.0007* |
1st with no siblings# | 1807 | 1353 | 1.34 (1.24–1.43) | 1.05 (0.96–1.16) | 0.2694∧ |
p-value for comparison of 1st-borns with siblings vs. 2nd or later-borns.
∧p-value for comparison of 1st-borns with no siblings vs. 2nd or later-borns.
# As of March 31st 2011.